Digital Health

FDA clears digital therapeutic for abdominal pain from IBS

MetaMe received FDA clearance for its first digital therapeutic on Tuesday. It uses behavioral therapy to help alleviate abdominal pain symptoms for patients with irritable bowel syndrome.
MedCity News
Now Reading:  
FDA clears digital therapeutic for abdominal pain from IBS

Digital Therapeutics are gaining traction and FDA approval

In this MedcityNews article, you'll learn about:
  • GI symptoms and therapy for patients with Irritable Bowl Syndrome (IBS)

  • MetaMe's app based solution to alleviating IBS symptoms

" The app uses self-directed hypnotherapy, with the idea of bringing people into a state of relaxation, and creating a sense of ease around their condition and symptoms. It’s intended to be used in conjunction with other treatments, which can include dietary changes or medications. "

  • Parameters around the FDA approval for MetaMe's digital therapeutic

"The FDA cleared it based on data from a randomized, controlled trial of 362 people, where half used Regulora for 12 weeks and the control group used a digital program for muscle relaxation therapy."

Read the full article here > >
This is some text inside of a div block.

Community Comments